maj 21, 2025 0 0 CELEX:62016CJ0680_SUM: Judgment of the Court (Fourth Chamber) of 27 March 2019.#Dr. August Wolff GmbH & Co. KG Arzneimittel and Remedia d.o.o. v European Commission.#Appeal — Medicinal products for human use — Directive 2001/83/EC — Article 30(1) — Committee for Medicinal Products for Human Use — Referral of a matter to the committee subject to the absence of a previous national decision — Active substance estradiol — Decision of the European Commission ordering the Member States to revoke or vary marketing authorisations for medicinal products with 0.01% estradiol by weight for topical use.#Case C-680/16 P.
julij 15, 2016 0 433 CELEX:62016CO0055: Sklep Sodišča (deveti senat) z dne 30. junija 2016.#Evo Bus GmbH proti Direcția Generală Regională a Finanțelor Publice Ploiești - Administrația Județeană a Finanțelor Publice Argeș
oktober 12, 2022 0 110 CELEX:62016CO0488: Ordonnance de la Cour (septième chambre) du 5 octobre 2022.#Freistaat Bayern contre Bundesverband Souvenir – Geschenke – Ehrenpreise eV.#Taxation des dépens.#Affaire C-488/16 P-DEP. This document does not exist in English.
april 12, 2023 0 95 CELEX:62016CO0488_INF: Order of the Court (Seventh Chamber) of 4 October 2022.#Freistaat Bayern v Bundesverband Souvenir – Geschenke – Ehrenpreise eV.#Case C-488/16 P-DEP.
november 20, 2023 0 0 CELEX:62016TA0131(01): Case T-131/16 RENV: Judgment of the General Court of 20 September 2023 — Belgium v Commission (State aid — Aid scheme put into effect by Belgium — Decision declaring the aid scheme incompatible with the internal market and unlawful and ordering recovery of the aid granted — Tax ruling — Taxable profit — Excess profit exemption — Advantage — Selectivity — Adverse effect on competition — Recovery)
november 20, 2023 0 0 CELEX:62016TA0201: Cases T-201/16, T-335/16, T-357/16 and T-369/16: Judgment of the General Court of 20 September 2023 — Soudal and Others v Commission (State aid — Aid scheme put into effect by Belgium — Decision declaring the aid scheme incompatible with the internal market and unlawful and ordering recovery of the aid granted — Tax ruling — Taxable profit — Excess profit exemption — Advantage — Selectivity — Recovery)
november 27, 2023 0 0 CELEX:62016TA0263: Cases T-263/16 RENV, T-265/16, T-311/16, T-319/16, T-321/16, T-343/16, T-350/16, T-444/16, T-800/16 and T-832/16: Judgment of the General Court of 20 September 2023 — Magnetrol International and Others v Commission (State aid — Aid scheme put into effect by Belgium — Decision declaring the aid scheme incompatible with the internal market and unlawful and ordering recovery of the aid granted — Tax ruling — Taxable profit — Excess profit exemption — Advantage — Selectivity — Recovery)
november 13, 2023 0 0 CELEX:62016TA0266: Case T-266/16, T-324/16, T-351/16, T-363/16, T-371/16 and T-388/16: Judgment of the General Court of 20 September 2023 — Capsugel Belgium and Others v Commission (State aid — Aid scheme put into effect by Belgium — Decision declaring the aid scheme incompatible with the internal market and unlawful and ordering recovery of the aid granted — Tax ruling — Taxable profit — Excess profit exemption — Advantage — Selectivity — Recovery)
november 20, 2023 0 0 CELEX:62016TA0278: Cases T-278/16 and T-370/16: Judgment of the General Court of 20 September 2023 — Atlas Copco Airpower and Others v Commission (State aid — Aid scheme put into effect by Belgium — Decision declaring the aid scheme incompatible with the internal market and unlawful and ordering recovery of the aid granted — Tax ruling — Taxable profit — Excess profit exemption — Advantage — Selectivity — Recovery)
marec 14, 2022 0 0 CELEX:62016TA0303: Case T-303/16: Judgment of the General Court of 26 January 2022 — Mylan IRE Healthcare v Commission (Medicinal products for human use — Orphan medicinal products — Marketing authorisations for the medicinal products Tobramycin VVB and associated names — Derogation from the market exclusivity of Tobi Podhaler, containing the active substance tobramycin — Article 8(3)(c) of Regulation (EC) No 141/2000 — Concept of ‘significant benefit’ — Concept of ‘clinical superiority’ — Article 3(2) and (3)(d) of Regulation (EC) No 847/2000 — Duty of care — Manifest error of assessment)